Acetaminophen

From NuGOwiki

Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Acetaminophen
2D structure for Acetaminophen
Chemical Name N-(4-hydroxyphenyl)acetamide
Chemical Formula C8H9NO2
CAS Number 103-90-2
Chemical Information HMDB01859
Biochemical Taxonomy

  • Misc

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways Not Available
Biofluid Location

  • Cerebrospinal Fluid (CSF)

Tissue Location

  • All Tissues

Normal Biofluid Concentrations

  • Cerebrospinal Fluid (CSF): 11 +/- 6 uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition Not Available
Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations Not Available
Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

Guidelines |guidelines]
The excellent tolerability of therapeutic doses of paracetamol (acetaminophen) is a major factor in the very wide use of the drug. The major problem in the use of paracetamol is its hepatotoxicity after an overdose. Hepatotoxicity has also been reported after therapeutic doses, but critical analysis indicates that most patients with alleged toxicity from therapeutic doses have taken overdoses. Importantly, prospective studies indicate that therapeutic doses of paracetamol are an unlikely cause of hepatotoxicity in patients who ingest moderate to large amounts of alcohol. (PMID 15733027) Single doses of paracetamol are effective analgesics for acute postoperative pain and give rise to few adverse effects. (PMID 14974073) Acetaminophen (AAP) overdose and the resulting hepatotoxicity is an important clinical problem. In addition, AAP is widely used as a prototype hepatotoxin to study mechanisms of chemical-induced cell injury and to test the hepatoprotective potential of new drugs and herbal medicines. Because of its importance, the mechanisms of AAP-induced liver cell injury have been extensively investigated and controversially discussed for many years. (PMID 16863451)

Biological Function

Function Guidelines |guidelines]

Catabolism

Related Guidelines |guidelines]

Diseases / Conditions Related to Nutrition

Related Diseases Guidelines |guidelines]


Other (Monogenic) Disorders

Diseases Guidelines |guidelines]


Nutritional Information

Information Guidelines |guidelines]

Drivers for biological variation

for biological variation Guidelines |guidelines]

Vulnerable groups

groups Guidelines |guidelines]

Other resources

resources Guidelines |guidelines]

Links

Guidelines |guidelines]